BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition.,
Duy, Cihangir, Hurtz Christian, Shojaee Seyedmehdi, Cerchietti Leandro, Geng Huimin, Swaminathan Srividya, Klemm Lars, Kweon Soo-Mi, Nahar Rahul, Braig Melanie, et al.
, Nature, 2011 May 19, Volume 473, Issue 7347, p.384-8, (2011)
Enhancer of zeste homolog 2 (EZH2) inhibitors.,
Gulati, Nitya, Béguelin Wendy, and Giulino-Roth Lisa
, Leuk Lymphoma, 2018 Jul, Volume 59, Issue 7, p.1574-1585, (2018)
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia.,
Saba, Nakhle S., Wong Deanna H., Tanios Georges, Iyer Jessica R., Lobelle-Rich Patricia, Dadashian Eman L., Liu Delong, Fontan Lorena, Flemington Erik K., Nichols Cydney M., et al.
, Cancer Res, 2017 Dec 15, Volume 77, Issue 24, p.7038-7048, (2017)
Mechanism-based epigenetic chemosensitization therapy of diffuse large B-cell lymphoma.,
Clozel, Thomas, Yang ShaoNing, Elstrom Rebecca L., Tam Wayne, Martin Peter, Kormaksson Matthias, Banerjee Samprit, Vasanthakumar Aparna, Culjkovic Biljana, Scott David W., et al.
, Cancer Discov, 2013 Sep, Volume 3, Issue 9, p.1002-19, (2013)
MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid Leukemia.,
Brown, Fiona C., Still Eric, Koche Richard P., Yim Christina Y., Takao Sumiko, Cifani Paolo, Reed Casie, Gunasekera Shehana, Ficarro Scott B., Romanienko Peter, et al.
, Cancer Discov, 2018 Apr, Volume 8, Issue 4, p.478-497, (2018)
Pathogenic role of B-cell receptor signaling and canonical NF-κB activation in mantle cell lymphoma.,
Saba, Nakhle S., Liu Delong, Herman Sarah E. M., Underbayev Chingiz, Tian Xin, Behrend David, Weniger Marc A., Skarzynski Martin, Gyamfi Jennifer, Fontan Lorena, et al.
, Blood, 2016 Jul 07, Volume 128, Issue 1, p.82-92, (2016)
PTEN opposes negative selection and enables oncogenic transformation of pre-B cells.,
Shojaee, Seyedmehdi, Chan Lai N., Buchner Maike, Cazzaniga Valeria, Cosgun Kadriye Nehir, Geng Huimin, Qiu Yi Hua, von Minden Marcus Dühren, Ernst Thomas, Hochhaus Andreas, et al.
, Nat Med, 2016 Apr, Volume 22, Issue 4, p.379-87, (2016)
Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma.,
Dupont, Thibault, Yang Shao Ning, Patel Jayeshkumar, Hatzi Katerina, Malik Alka, Tam Wayne, Martin Peter, Leonard John, Melnick Ari, and Cerchietti Leandro
, Oncotarget, 2016 Jan 19, Volume 7, Issue 3, p.3520-32, (2016)
SYK inhibition and response prediction in diffuse large B-cell lymphoma.,
Cheng, Shuhua, Coffey Greg, X Zhang Hannah, Shaknovich Rita, Song Zibo, Lu Pin, Pandey Anjali, Melnick Ari M., Sinha Uma, and Y Wang Lynn
, Blood, 2011 Dec 08, Volume 118, Issue 24, p.6342-52, (2011)